Skip to main content
. 2020 Sep 11;9(9):81. doi: 10.1038/s41389-020-00265-z

Fig. 2. The qualification of ECSC pluripotency.

Fig. 2

a Morphology of ECSCisk and ECSCecc and immunofluorescent staining of ALDH1 and SOX2. b FACS detection of ALDH1 and CD133 in ECSCisk and ECSCecc. c qRT-PCR analysis of stemness genes (ALDH1, CD133, OCT4, SOX2 and NANOG) in ECSCisk and ECSCecc. d SOX2 protein expression by western blot in different ECSCs and control cells (ISK). e EMT gene expression in ECSCisk. f FACS data of the percentages of cells positive for ALDH1 and CD133 in two human samples and ECSCisk. g Statistics of the percentage of CD133-positive cells in ECSCisk. Mean ± SEM (N = 3). */#P < 0.05, **/##P < 0.01, and ***/###P < 0.001.